Charles Barker, one of the Cannabis Regulatory Commission’s most outspoken critics of big cannabis corporations, is being ...

Clarity Pharmaceuticals Ltd ( ASX:CU6 ) is possibly approaching a major achievement in its business, so we would ...

Effective provider segmentation can make or break a new drug launch, and can also improve the lifecycle of existing portfolio ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

Catherine Longworth is the Editor for Medical Device Network, covering developments across the medical technology and health ...

Dhanendra Kumar’s article, “Intellectual Property and Competition Law: Two Sides of the Same Coin,” in Business Standard, examines the complex relationship between intellectual property rights and ...

Lynne Merriam was working as a nurse in an emergency room in the early 1990s when a leadership position in the research ...

Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

Mass photometry’s unique bioanalytical workflow capabilities recognized by the scientific community, with over 500 scientific ...

Purdue Global Health Sciences dean Rebecca Zolotor is using her breadth of knowledge and experience to move the school forward into the future, setting up students for career success.

IMIDomics, Inc., a pioneering private company focused on advancing precision medicines for immune-mediated inflammatory diseases (IMIDs), announced today that effective October 1, 2024, Matthias Evers ...